Product
E7 TCR-T cells
1 clinical trial
20 indications
Indication
Cervical CancerIndication
throat cancerIndication
Oropharyngeal CancerIndication
Anal CancerIndication
Vulvar CancerIndication
Vaginal CancerIndication
Penile CancerIndication
Metastatic CancerIndication
HPV-related malignancyIndication
Human Papillomavirus-Related CarcinomaIndication
HPV-Related Squamous Cell CarcinomaIndication
HPV-Related AdenocarcinomaIndication
Vaginal AdenocarcinomaIndication
HPV-Related Adenosquamous CarcinomaIndication
HPV-Related Endocervical AdenocarcinomaIndication
Anal Squamous Cell CarcinomaIndication
Penile squamous cell carcinomaIndication
Vulvar Squamous Cell CarcinomaIndication
Rectal Squamous Cell CarcinomaClinical trial
A Phase II Trial of T Cell Receptor Gene Therapy Targeting Human Papillomavirus ( HPV) 16 E7 for HPV-Associated CancersStatus: Recruiting, Estimated PCD: 2025-01-01